University of Houston

Columbia University

IEEE Brain

IEEE Life Sciences

Technical University of Crete

Past Editions:

Biocomplexity 2022

Biocomplexity 2019Biocomplexity 2018

Biocomplexity 2017Biocomplexity 2016

Biocomplexity 2015Biocomplexity 2014

Biocomplexity 2013Biocomplexity 2012

Biocomplexity 2011Biocomplexity 2010

Biocomplexity 2009Biocomplexity 2009

Biocomplexity 2007Biocomplexity 2005

Biocomplexity 2004Biocomplexity 2003

Biocomplexity 2002Biocomplexity 2001



Dr. Natalie Mrachacz-Kersting

Dr. Natalie Mrachacz-Kersting

Dr. Natalie Mrachacz-Kersting received her PhD in Biomedical Science and Engineering from The University of Aalborg, Denmark in 2005 and held several post-doctoral positions at the University of Auckland, New Zealand and Aalborg University, Denmark. From 2007 she was Associate Professor at the Center for Sensory-Motor Interaction, Aalborg University, and in 2019 Professor in Neuroscience and Medical Technologies at the University of Applied Sciences and Arts Dortmund, Germany. In June 2021 she accepted a position as full Professor in Neuroscience and Director of the Institute at the University of Freiburg, Germany. Her research focuses on neurorehabilitation technology for the restoration and replacement of lost motor function, and neural control of movement. She has (co)-authored more than 80 manuscripts in peer-reviewed Journals and >170 conference abstracts andpapers. She was the recipient of the International Award in Brain-Computer-Interfaces in 2017 and received several prestigious grants from the Innovation Fond of Denmark, Kong Christian den Tiendes Fond and Lundbeck Fond of Denmark.

Dr. Mrachacz-Kersting is currently Board Member of the Brain-Computer Interface Society where she also heads the fundraising committee and is part of the communications committee. She is Associate-Editor of several journals including Transactions on Neural Systems and Rehabilitation Engineering, Brain-Computer-Interfaces, Scandinavian Journal of Medicine and Science in Sports and Frontiers in Human Neuroscience. In Freiburg she was recently appointed director of the student health management group that collaborates with health insurances to provide the student body with innovative opportunities to improve health in all aspects from psychological stress to time management.
Dr. Colin J.H. Brenan

Dr. Colin J.H. Brenan

Dr. Colin J.H. Brenan is a serial life sciences entrepreneur who is presently the CEO of Kibur Medical Inc., an early-stage company commercializing a novel approach to precision cancer therapies and diagnostics from simultaneous and in situ molecular profiling of tumor response to up to 20 drugs or drug combinations with an implantable microdevice. Previously he was Founder/CEO and Director of the single cell instrumentation company 1CellBio Inc. (www.1cell-bio.com); formerly Founder/Chief Commercial Officer and Director of antibody drug developer HiFiBiO Ltd (www.hifibio.com); and, Managing Director of the Monsanto-Atlas Seed Fund Alliance at Atlas Venture (Cambridge, USA) where he identified and invested in seed and early-stage life science companies.

Prior to Atlas, Dr. Brenan was Director of Strategic Relationships for the Center for Integration of Medicine and Innovative Technology (CIMIT) – a Partners Healthcare innovation center (Boston, MA). Before joining CIMIT, Dr. Brenan was the Founder, Chief Technology Officer, SVP, Business Development and a Director of BioTrove Inc. (Woburn, USA), commercializing the OpenArrayTM, a nanofluidic PCR array, acquired by Life Technologies Inc. (LIFE:NASDAQ); and a Founder of the high throughput mass spectrometry company Biocius Inc., commercializing the RapidFireTM product spun-out from BioTrove and acquired by Agilent Inc. (A:NYSE).

Dr. Brenan is the inventor on 26 US patents, 27 non-US patents, +60 patent applications and published +50 peer-reviewed journal articles, book chapters and reports in the fields of bio-microsystems, confocal microscopy, spectroscopic imaging, drug discovery and microsurgical robotics. He has over a decade of experience in consulting for the US National Institutes of Health and is an active member of the IEEE EMBS. Dr. Brenan received his B.Sc. (Honours Physics), M. Eng. (Electrical), and Ph.D. (Biomedical Engineering) from McGill University (Montreal, Canada) and completed post-doctoral training at MIT (Cambridge, USA).
Dr. Rose Faghih

Dr. Rose Faghih

Dr. Rose Faghih is an associate professor of Biomedical Engineering at the New York University (NYU) where she directs the Computational Medicine Laboratory located within the NYU Langone Health’s Tech4Health Institute. Prior to joining NYU, she was an assistant professor of Electrical and Computer Engineering at the University of Houston. The goal of her research is to develop algorithms for designing MINDWATCH, i.e., smartwatches of the future that can monitor brain activity and use simple, everyday actuators (e.g., music or light) to improve mental health and performance. She received her bachelor’s degree (summa cum laude) in Electrical Engineering (Honors Program Citation) from the University of Maryland, and S.M. and Ph.D. degrees in Electrical Engineering and Computer Science with a minor in Mathematics from the Massachusetts Institute of Technology (MIT), where she was a member of the MIT Laboratory for Information and Decision Systems as well as the MIT-Harvard Neuroscience Statistics Research Laboratory. She completed her postdoctoral training at the Department of Brain and Cognitive Sciences and the Picower Institute for Learning and Memory at MIT as well as the Department of Anesthesia, Critical Care and Pain Medicine at the Massachusetts General Hospital. She is a senior member of IEEE and recipient of different awards such as an MIT Technology Review 2020 Innovator Under 35 award, a 2020 National Science Foundation CAREER Award, a 2020 Research Excellence award as well as a 2020 Teaching Excellence Award from the University of Houston’s Cullen College of Engineering, a 2016 IEEE-USA New Face of Engineering award, a National Science Foundation Graduate Research Fellowship, an MIT Graduate Fellowship, and the University of Maryland’s Department of Electrical and Computer Engineering Chair’s Award. Moreover, she was selected by the National Academy of Engineering for the 2019 U.S. Frontiers of Engineering Symposium. In 2020, she was featured by the IEEE Women in Engineering Magazine as a “Woman to Watch”. Furthermore, she has been inducted into various honor societies including Phi Kappa Phi, Tau Beta Pi, and Eta Kappa Nu. Her research interests include wearable technologies, medical cyber-physical systems, and control, estimation and system identification of biomedical and neural systems.

Dr. Dimitrios I. Fotiadis

Dr. Dimitrios I. Fotiadis

Dr. Dimitris I. Fotiadis Dimitris I. Fotiadis (Fellow, IEEE) was born in Ioannina, Greece in 1961. He received the Diploma degree from the National Technical University of Athens, Athens, Greece, in 1985, and the Ph.D. degree from the University of Minnesota, Minneapolis, MN, USA, in 1990, respectively, all in chemical engineering. He is currently a Professor of Biomedical Engineering in the Department of Materials Science and Engineering, University of Ioannina, Ioannina, Greece, where he is also the Director of the Unit of Medical Technology and Intelligent Information Systems, and is also an Affiliated Member of the Foundation for Research and Technology Hellas, Institute of Molecular Biology and Biotechnology, Department of Biomedical Research. He was a Visiting Researcher at the RWTH, Aachen, Germany, and the Massachusetts Institute of Technology, Cambridge, MA, USA. He has coordinated and participated in more than 200 R&D funded projects (in FP6, FP7, H2020, and national projects), being the coordinator and technical coordinator in several of them. Prof. Fotiadis is an IEEE EMBS Fellow, EAMBES Fellow, Fellow of IAMBE, member of the IEEE Technical Committee of Information Technology in Healthcare, Editor-in-Chief of IEEE Journal of Biomedical and Health Informatics, Associate Editor of IEEE Reviews in Biomedical Engineering, IEEE Open Journal in Engineering in Medicine and Biology, and Computers in Biology and Medicine. His current research interests include multiscale modeling of human tissues and organs, intelligent wearable/implantable devices for automated diagnosis, processing of big medical data, machine learning, sensor informatics, image informatics, and bioinformatics. He is the recipient of many scientific awards including the one by the Academy of Athens.

Dr. Anthony Guiseppi-Elie

Dr. Anthony Guiseppi-Elie

Dr. Anthony Guiseppi-Elie is an international engineering and innovation consultant. He was Chief Academic Officer and VP of Academic Affairs and Workforce Development at Tri-Country Technical College. He is the Founding Dean of the College of Engineering and former VP of Industry Relations, and University Distinguished Professor at Anderson University. He was Associate Dean of Engineering Innovation in the School of Engineering Medicine (ENMED) at Texas A&M University (TAMU) and Houston Methodist Hospital (HMH). At TAMU he was also TEES Research Professor, Professor of Biomedical Engineering and Professor of Electrical and Computer Engineering. At Houston Methodist Hospital, he was Full Affiliate Member of the Houston Methodist Research Institute and Professor in the Department of Cardiovascular Sciences. He was Department Head of Biomedical Engineering and Director of the TEES Division of Biomedical Engineering at TAMU and directed the Bioelectronics, Biosensors and Biochips (C3B®) Laboratories. He is Founder, President, and Scientific Director of ABTECH Scientific, Inc., a near-patient biomedical diagnostics company. He holds the Sc.D. in Materials Science and Engineering from MIT, the M.Sc. in Chemical Engineering (Corrosion Science and Engineering) from the University of Manchester (UMIST), and the B.Sc. (First Class Honors) with majors in Chemistry, Analytical Chemistry, Biochemistry, and Applied Chemistry from the University of the West Indies (UWI). He has spent 15 years in industrial research and product development at WR Grace & Co, Molecular Electronics Corporation, and ABTECH Scientific, Inc., before becoming a full Professor of Chemical and Life Science Engineering (1998) and Professor of Emergency Medicine (2000) at Virginia Commonwealth University/ Medical College of Virginia. In 2006, he joined Clemson University as the Dow Chemical Professor with appointments in Chemical and Biomolecular Engineering, Bioengineering, and Electrical and Computer Engineering. Prof. Guiseppi-Elie is a 2015-2010 Fulbright Specialist awardee (Argentina, Poland). He is a Fellow of the American Institute of Medical and Biological Engineering (2006), the Royal Society of Chemistry (2014), the Institute of Electrical and Electronic Engineers (2016) and the Biomedical Engineering Society (2020). He is a Lifetime Member of AIChE and holds memberships in AAAS, ACS, MRS, AAPS and BMES. He was the 2017-18 Chair of the AIMBE College of Fellows. He is a graduate of the Academic Leadership Academy at Penn State University and serves on the External Advisory Boards of the BME Department at the University of Florida, the Fowler College of Engineering at Chapman University, the Department of Chemistry at Clark Atlanta University, STEAM-E, and The Council for Frontiers of Knowledge, Uganda. Prof. Guiseppi has taught innovation, entrepreneurship, biomolecular and cellular engineering, biosensors and bioelectronics, biological transport phenomena, and nanobiotechnology. His scholarly research interests are in engineered bioanalytical microsystems in the service of human health and medicine. He has published over 225 archival scientific papers (9,156 citations, h-index = 48), 33 book or proceedings chapters, holds 8 US patents/disclosures, and has given more than 200 invited lectures/colloquia. He is Founding Editor-in-Chief of Bioengineering (IF = 5.046). His research work has been acknowledged by being named to the top 1,000 Black life scientists in the USA (2020).

Dr. Chwee Teck Lim

Dr. Chwee Teck Lim

Dr. Chwee Teck Lim is the NUSS Chair Professor at the Department of Biomedical Engineering and Director of the Institute for Health Innovation and Technology at the National University of Singapore. He conducts research in human diseases and develops medical sensing and wearable technologies for disease diagnosis and therapy. He has over 450 scientific publications, delivered over 420 plenary/lkeynote/invited talks and ha over 60 filed and granted patents. He also cofounded six startups. He and his team has garnered over 100 research awards and honours including elected fellowships in the US National Academy of Inventors, IUPESM, IAMBE, AIMBE, ASEAN Academy of Engineering and Technology, Academy of Engineering, Singapore and Singapore National Academy of Science.

Tammy Riklin Raviv

Dr. Tammy Riklin Raviv

Prof. Tammy Riklin Raviv leads the Biomedical Image Computing lab. at the School of Electrical and Computer Engineering of Ben-Gurion University of the Negev(BGU). Her lab. develops Deep Learning and Computer Vision algorithms for Medical and Microscopy Imaging Analysis and Computational Neuroscience. She is currently a TC member at the IEEE Bio Imaging and Signal Processing (BISP) Committee (her first term ends at the beginning of 2023 and as an associate editor at the IEEE Transactions on Medical Imaging journal. She also serves on the steering committee of the IEEE International Symposium on Biomedical Imaging (ISBI) 2023, the organizing committee Medical Image Computing and Computer Aided Intervention (MICCAI) 2024, and the organizing committee of the CVPR Medical Computer Vision (MCV) workshop 2023. She holds a B.Sc. in Physics and an M.Sc. in Computer Science, both from the Hebrew University in Jerusalem and a PhD from the School of Electrical Engineering of Tel-Aviv University. Prior to establishing her research group at BGU (2012) she was a research fellow and a post-doctorate associate at the Computer Science and Artificial Intelligence lab. (CSAIL), MIT, at Harvard Medical School, and the Broad Institute of MIT and Harvard

Dr. Ali Tinazli

Dr. Ali Tinazli

Dr. Ali Tinazli joined lifespin in Summer 2021 in Germany as CEO and has a deep background in the science and business of biomedicine and healthcare as well as technology convergence between digital/consumer technologies and healthcare. Tinazli received his Ph.D. in Biochemistry from J.W. Goethe University in Germany, and also studied business at UC, Berkeley’s Haas School of Business and MIT’s Sloan School of Management. Ali has done extensive work in the field of the molecular biology of aging and nanobiotechnology and has authored about 20 publications. After receiving his Ph.D., Ali was in Corporate Development at Applied Biosystems (now: Thermo Fisher) where he conducted technology scouting and in-licensing. From 2008-2015, Dr. Tinazli built the biomedical consumables business at Sony DADC (part of SONY Corporation). As a member of the management team at Sony DADC BioSciences, he has headed as VP & Head of Business Development the Americas business based out of Cambridge, MA. From 2015-2019 Ali was leading Hewlett-Packard’s global healthcare strategy in Palo Alto (CA, USA) and joined point-of-care diagnostics start-up Fluxergy in Irvine (CA, USA) as CCO after. In addition to his bioscience and industry domain expertise, Ali brings strong entrepreneurial experience and hands-on knowledge of the biosciences start-up community and serves as Board Member and Angel Investor in numerous start-ups ranging from cybersecurity to oncology.

Prof. May D. Wang

Dr. May D. Wang

Dr. May D. Wang is a full professor, GCC distinguished cancer scholar and Director of Biocomputing and Bioinformatics Core in Emory-Georgia Tech Cancer Nanotechnology Center at the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. Dr. Wang's primary research interest is biomedical and health informatics in systems medicine and healthcare, with the goal to speed up the discovery, development, and translation in modern biology, medicine, and health. She has played an active role in several working groups within National Cancer Institute (NCI/NIH) cancer Biomedical Informatics Grid (caBIG), and FDA-led Microarray Quality Control Consortium (MAQC) on biomarker and nanomedicine for personalized medicine. As the corresponding or co-corresponding author, Dr. Wang has published in journals such as Annals of Biomedical Eng, BMC Bioinformatics, Trends in Biotechnology, Nature Protocols, Proceedings of National Academy of Sciences, Annual Review of Medicine, and the Pharmacogenomics Journal.

Dr. Wang received Distinguished Cancer Scholar Award from Georgia Cancer Coalition in 2004, an Outstanding Undergraduate Research Faculty Mentor Award from Georgia Tech in 2005, and an Outstanding Service Award from IEEE BIBE in 2007. She is appointed as the Chair of Technical Committee on Information Technology for Health in IEEE Engineering in Medicine and Biology Society (EMBS) in 2011, and serves as associate editors for a couple of journals. Dr. Wang received Ph.D.EE, multidisciplinary MS degrees (EE, Applied Math, and CS) from Georgia Institute of Technology in USA, and BEng from Tsinghua University in China. In addition, Dr. Wang has several years of industrial R&D experience in the former AT&T Bell Labs, Intel Architecture Labs, Hughes Research Labs, Lucent Technologies Bell Labs, and Agere Systems. Dr. Wang was inducted to the College of Fellows of AIMBE.